Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
BioAge Labs
Biotech
Biophama VC, deal values and exits all rise in Q3: Pitchbook
Biopharma brought in $7.2 billion across 187 deals in 2024's third quarter, jumping from $5.8 billion in the second quarter.
Gabrielle Masson
Nov 20, 2024 6:15am
BioAge brings in $198M from IPO as obesity biotech joins Nasdaq
Sep 26, 2024 4:44am
BioAge eyes $180M from IPO, private placement for obesity trials
Sep 25, 2024 7:55am
UPDATE: Lilly-backed metabolic disease biotech files IPO
Sep 4, 2024 10:23am
Ex-GSK CEO takes up board post at aging, obesity biotech BioAge
Aug 22, 2024 10:09am
Sands Capital raises new $555M life sci fund
May 14, 2024 10:30am
